{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:27:15Z","timestamp":1793104035017,"version":"4.5.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00203-026-04774-0","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T10:24:41Z","timestamp":1772533481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Phage therapy for treatment of bacterial vaginosis"],"prefix":"10.1007","volume":"208","author":[{"given":"Sara","family":"Mazinani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Arjmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Sheikh Soleimany Darany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjes","family":"Habibimoghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada Khairi","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhwan Abdul","family":"Kareem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder Naji","family":"Sameer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohaned","family":"Adil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma Sanjari","family":"Pour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"4774_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/v17081094","volume":"17","author":"ST Abedon","year":"2025","unstructured":"Abedon ST (2025) Phage therapy: combating evolution of bacterial resistance to phages. Viruses 17:1094","journal-title":"Viruses"},{"key":"4774_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/ph14101019","volume":"14","author":"ST Abedon","year":"2021","unstructured":"Abedon ST, Danis-Wlodarczyk KM, Wozniak DJ (2021) Phage cocktail development for bacteriophage therapy: toward improving spectrum of activity breadth and depth. Pharmaceuticals 14:1019","journal-title":"Pharmaceuticals"},{"key":"4774_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3109\/23744235.2016.1160421","volume":"48","author":"MH Ahmadi","year":"2016","unstructured":"Ahmadi MH, Mirsalehian A, Bahador A (2016) Association of chlamydia trachomatis with infertility and clinical manifestations: a systematic review and meta-analysis of case-control studies. Infect Dis 48:517\u2013523","journal-title":"Infect Dis"},{"key":"4774_CR4","doi-asserted-by":"crossref","unstructured":"Algburi A, Zehm S, Netrebov V, Weeks R, Zubovskiy K, Chikindas ML (2018) Benzoyl peroxide inhibits quorum sensing and biofilm formation by Gardnerella vaginalis 14018. Infectious diseases in obstetrics and gynecology 2018:1426109","DOI":"10.1155\/2018\/1426109"},{"key":"4774_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40168-022-01317-9","volume":"10","author":"L Anton","year":"2022","unstructured":"Anton L, Ferguson B, Friedman ES, Gerson KD, Brown AG, Elovitz MA (2022) Gardnerella vaginalis alters cervicovaginal epithelial cell function through microbe-specific immune responses. Microbiome 10:119","journal-title":"Microbiome"},{"key":"4774_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41522-022-00285-0","volume":"8","author":"S Arroyo-Moreno","year":"2022","unstructured":"Arroyo-Moreno S, Cummings M, Corcoran DB, Coffey A, McCarthy RR (2022) Identification and characterization of novel endolysins targeting Gardnerella vaginalis biofilms to treat bacterial vaginosis. Npj Biofilms Microbiomes 8:29","journal-title":"Npj Biofilms Microbiomes"},{"key":"4774_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3121\/cmr.2021.1605","volume":"19","author":"VH Aswani","year":"2021","unstructured":"Aswani VH, Shukla SK (2021) An early history of phage therapy in the united states: is it time to reconsider? Clin Med Res 19:82\u201389","journal-title":"Clin Med Res"},{"key":"4774_CR8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/22221751.2020.1747950","volume":"9","author":"J Bao","year":"2020","unstructured":"Bao J et al (2020) Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae. Emerg Microbes Infections 9:771\u2013774","journal-title":"Emerg Microbes Infections"},{"key":"4774_CR9","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.amepre.2016.09.016","volume":"52","author":"CT Bautista","year":"2017","unstructured":"Bautista CT, Wurapa EK, Sateren WB, Morris SM, Hollingsworth BP, Sanchez JL (2017) Association of bacterial vaginosis with chlamydia and gonorrhea among women in the US army. Am J Prev Med 52:632\u2013639","journal-title":"Am J Prev Med"},{"key":"4774_CR10","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s11274-009-9991-8","volume":"25","author":"MS Bedi","year":"2009","unstructured":"Bedi MS, Verma V, Chhibber S (2009) Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055. World J Microbiol Biotechnol 25:1145\u20131151","journal-title":"World J Microbiol Biotechnol"},{"key":"4774_CR11","unstructured":"Bhattacharya S, Johnson N, Tijani HA, Hart R, Pandey S, Gibreel AF (2010) Female infertility. BMJ Clin Evid 2010"},{"key":"4774_CR12","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1016\/j.biomaterials.2012.03.054","volume":"33","author":"SR Bhattarai","year":"2012","unstructured":"Bhattarai SR, Yoo SY, Lee S-W, Dean D (2012) Engineered phage-based therapeutic materials inhibit chlamydia trachomatis intracellular infection. Biomaterials 33:5166\u20135174","journal-title":"Biomaterials"},{"key":"4774_CR13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41587-019-0100-8","volume":"37","author":"H Bin Jang","year":"2019","unstructured":"Bin Jang H et al (2019) Taxonomic assignment of uncultivated prokaryotic virus genomes is enabled by gene-sharing networks. Nat Biotechnol 37:632\u2013639","journal-title":"Nat Biotechnol"},{"key":"4774_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/amh70020019","volume":"70","author":"A Borrego-Ruiz","year":"2025","unstructured":"Borrego-Ruiz A, Borrego JJ (2025) Microbial pathogens linked to vaginal Microbiome dysbiosis and therapeutic tools for their treatment. Acta Microbiol Hellenica 70:19","journal-title":"Acta Microbiol Hellenica"},{"key":"4774_CR16","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1093\/infdis\/jiw159","volume":"214","author":"CS Bradshaw","year":"2016","unstructured":"Bradshaw CS, Sobel JD (2016) Current treatment of bacterial vaginosis\u2014limitations and need for innovation. J Infect Dis 214:S14\u2013S20","journal-title":"J Infect Dis"},{"key":"4774_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-025-00626-1","volume":"11","author":"CS Bradshaw","year":"2025","unstructured":"Bradshaw CS et al (2025) Bacterial vaginosis. Nat Reviews Disease Primers 11:43","journal-title":"Nat Reviews Disease Primers"},{"key":"4774_CR17","first-page":"1","volume":"10","author":"A Brazdova","year":"2016","unstructured":"Brazdova A, Senechal H, Peltre G, Poncet P (2016) Immune aspects of female infertility. Int J Fertility Steril 10:1","journal-title":"Int J Fertility Steril"},{"key":"4774_CR18","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/mmi.14134","volume":"110","author":"SS Broendum","year":"2018","unstructured":"Broendum SS, Buckle AM, McGowan S (2018) Catalytic diversity and cell wall binding repeats in the phage-encoded endolysins. Mol Microbiol 110:879\u2013896","journal-title":"Mol Microbiol"},{"key":"4774_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12905-023-02260-z","volume":"23","author":"J Brusselmans","year":"2023","unstructured":"Brusselmans J, De Sutter A, Devleesschauwer B, Verstraelen H, Cools P (2023) Scoping review of the association between bacterial vaginosis and emotional, sexual and social health. BMC Womens Health 23:168","journal-title":"BMC Womens Health"},{"key":"4774_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fcimb.2020.00083","volume":"10","author":"J Castro","year":"2020","unstructured":"Castro J, Rosca AS, Cools P, Vaneechoutte M, Cerca N (2020) Gardnerella vaginalis enhances atopobium vaginae viability in an in vitro model. Front Cell Infect Microbiol 10:83","journal-title":"Front Cell Infect Microbiol"},{"key":"4774_CR21","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/antibiotics11050558","volume":"11","author":"J Castro","year":"2022","unstructured":"Castro J, Sousa LG, Fran\u00e7a \u00c2, Podpera Tisakova L, Corsini L, Cerca N (2022) Exploiting the anti-biofilm effect of the engineered phage endolysin PM-477 to disrupt in vitro single-and dual-species biofilms of vaginal pathogens associated with bacterial vaginosis. Antibiotics 11:558","journal-title":"Antibiotics"},{"key":"4774_CR22","doi-asserted-by":"publisher","first-page":"631972","DOI":"10.3389\/fcimb.2021.631972","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X, Lu Y, Chen T, Li R (2021) The female vaginal Microbiome in health and bacterial vaginosis. Front Cell Infect Microbiol 11:631972","journal-title":"Front Cell Infect Microbiol"},{"key":"4774_CR23","doi-asserted-by":"publisher","first-page":"e56022","DOI":"10.1371\/journal.pone.0056022","volume":"8","author":"S Chhibber","year":"2013","unstructured":"Chhibber S, Kaur T, Kaur S (2013) Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections. PLoS ONE 8:e56022","journal-title":"PLoS ONE"},{"key":"4774_CR24","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","volume":"25","author":"RM Dedrick","year":"2019","unstructured":"Dedrick RM et al (2019) Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med 25:730\u2013733","journal-title":"Nat Med"},{"key":"4774_CR25","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/cid\/ciz429","volume":"69","author":"CD Den Heijer","year":"2019","unstructured":"Den Heijer CD et al (2019) Chlamydia trachomatis and the risk of pelvic inflammatory disease, ectopic pregnancy, and female infertility: a retrospective cohort study among primary care patients. Clin Infect Dis 69:1517\u20131525","journal-title":"Clin Infect Dis"},{"key":"4774_CR26","doi-asserted-by":"crossref","unstructured":"Drulis-Kawa Z, Augustyniak D (2022) Phage\u2013Bacteria interplay in health and disease. MDPI, Basel p 1054","DOI":"10.3390\/v14051054"},{"key":"4774_CR27","doi-asserted-by":"crossref","unstructured":"Dub\u00e9-Zinatelli E, Cappelletti L, Ismail N (2025) The vaginal Microbiome in bacterial vaginosis: Pathogenesis, reproductive Impacts, and emerging therapies. J Reprod Immunol 172:104804","DOI":"10.1016\/j.jri.2025.104804"},{"key":"4774_CR28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.medmal.2008.06.016","volume":"38","author":"A Dublanchet","year":"2008","unstructured":"Dublanchet A, Fruciano E (2008) Br\u00e8ve histoire de La phagoth\u00e9rapie. M\u00e9d Mal Infect 38:415\u2013420","journal-title":"M\u00e9d Mal Infect"},{"key":"4774_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/OLQ.0000000000001821","volume":"50","author":"JH Elnaggar","year":"2023","unstructured":"Elnaggar JH et al (2023) Characterization of vaginal microbial community dynamics in the pathogenesis of incident bacterial vaginosis, a pilot study. Sex Transm Dis 50:523\u2013530","journal-title":"Sex Transm Dis"},{"key":"4774_CR30","doi-asserted-by":"crossref","unstructured":"Essa N, Rossitto M, Fiscarelli EV (2020) Phages and phage therapy: past, present and future. Microbiol Med 35","DOI":"10.4081\/mm.2020.8709"},{"key":"4774_CR31","doi-asserted-by":"publisher","first-page":"e30633","DOI":"10.1371\/journal.pone.0030633","volume":"7","author":"K Fethers","year":"2012","unstructured":"Fethers K et al (2012) Bacterial vaginosis (BV) candidate bacteria: associations with BV and behavioural practices in sexually-experienced and inexperienced women. PLoS ONE 7:e30633","journal-title":"PLoS ONE"},{"key":"4774_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/microorganisms12020253","volume":"12","author":"J Fletcher","year":"2024","unstructured":"Fletcher J et al (2024) The citizen phage library: rapid isolation of phages for the treatment of antibiotic resistant infections in the UK. Microorganisms 12:253","journal-title":"Microorganisms"},{"key":"4774_CR33","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1038\/s41598-025-88208-9","volume":"15","author":"P Foessleitner","year":"2025","unstructured":"Foessleitner P et al (2025) Association between changes in genital immune markers and vaginal Microbiome transitions in bacterial vaginosis. Sci Rep 15:3536","journal-title":"Sci Rep"},{"key":"4774_CR34","doi-asserted-by":"crossref","unstructured":"France M et al (2025) VIRGO2: Unveiling the Functional and Ecological Complexity of the Vaginal Microbiome with an Enhanced Non-Redundant Gene Catalog. bioRxiv","DOI":"10.1101\/2025.03.04.641479"},{"key":"4774_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fcimb.2018.00376","volume":"8","author":"LL Furfaro","year":"2018","unstructured":"Furfaro LL, Payne MS, Chang BJ (2018) Bacteriophage therapy: clinical trials and regulatory hurdles. Front Cell Infect Microbiol 8:376","journal-title":"Front Cell Infect Microbiol"},{"key":"4774_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.15570\/actaapa.2019.35","volume":"28","author":"M Gajd\u00e1cs","year":"2019","unstructured":"Gajd\u00e1cs M, Zsoldin\u00e9 Urb\u00e1n E (2019) Epidemiology and resistance trends of Staphylococcus aureus isolated from vaginal samples: a 10-year retrospective study in Hungary. Acta Dermatovenerologica Alpina Pannonica Et Adriatica 28:143\u2013147","journal-title":"Acta Dermatovenerologica Alpina Pannonica Et Adriatica"},{"key":"4774_CR37","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3389\/fmicb.2019.01187","volume":"10","author":"R Garc\u00eda","year":"2019","unstructured":"Garc\u00eda R, Latz S, Romero J, Higuera G, Garc\u00eda K, Bast\u00edas R (2019) Bacteriophage production models: an overview. Front Microbiol 10:1187","journal-title":"Front Microbiol"},{"key":"4774_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s44259-025-00123-1","volume":"3","author":"N Gargate","year":"2025","unstructured":"Gargate N, Laws M, Rahman KM (2025) Current economic and regulatory challenges in developing antibiotics for Gram-negative bacteria. NPJ Antimicrob Resist 3:50. https:\/\/doi.org\/10.1038\/s44259-025-00123-1","journal-title":"NPJ Antimicrob Resist"},{"key":"4774_CR39","doi-asserted-by":"publisher","unstructured":"Gerede A et al (2024) Vaginal Microbiome and pregnancy complications: A review. J Clin Med 13. https:\/\/doi.org\/10.3390\/jcm13133875","DOI":"10.3390\/jcm13133875"},{"key":"4774_CR40","doi-asserted-by":"publisher","first-page":"105980","DOI":"10.1016\/j.micpath.2023.105980","volume":"175","author":"O Gholizadeh","year":"2023","unstructured":"Gholizadeh O et al (2023) Review of the evidence of the effects of human papillomavirus infection and Gardnerella vaginalis, and their co-infection on infertility. Microb Pathog 175:105980","journal-title":"Microb Pathog"},{"key":"4774_CR41","doi-asserted-by":"publisher","first-page":"1320345","DOI":"10.3389\/fmicb.2023.1320345","volume":"14","author":"M Gli\u017aniewicz","year":"2024","unstructured":"Gli\u017aniewicz M et al (2024) Advances in bacteriophage-mediated strategies for combating polymicrobial biofilms. Front Microbiol 14:1320345","journal-title":"Front Microbiol"},{"key":"4774_CR42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41564-020-00830-7","volume":"6","author":"F Gordillo Altamirano","year":"2021","unstructured":"Gordillo Altamirano F et al (2021) Bacteriophage-resistant acinetobacter baumannii are resensitized to antimicrobials. Nat Microbiol 6:157\u2013161. https:\/\/doi.org\/10.1038\/s41564-020-00830-7","journal-title":"Nat Microbiol"},{"key":"4774_CR43","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/cid\/ciu831","volume":"60","author":"J Gratrix","year":"2015","unstructured":"Gratrix J et al (2015) Evidence for increased chlamydia case finding after the introduction of rectal screening among women attending 2 Canadian sexually transmitted infection clinics. Clin Infect Dis 60:398\u2013404","journal-title":"Clin Infect Dis"},{"key":"4774_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/apm.13362","volume":"132","author":"B Grygorcewicz","year":"2024","unstructured":"Grygorcewicz B et al (2024) Bacteriophage-based approach for treatment of urinary tract infections: a quick outlook. APMIS 132:81\u201393","journal-title":"APMIS"},{"key":"4774_CR45","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3389\/fmicb.2017.01162","volume":"8","author":"VK Gupta","year":"2017","unstructured":"Gupta VK, Paul S, Dutta C (2017) Geography, ethnicity or subsistence-specific variations in human Microbiome composition and diversity. Front Microbiol 8:1162","journal-title":"Front Microbiol"},{"key":"4774_CR46","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/sextrans-2015-052285","volume":"92","author":"CL Haggerty","year":"2016","unstructured":"Haggerty CL et al (2016) Identification of novel microbes associated with pelvic inflammatory disease and infertility. Sex Transm Infect 92:441\u2013446","journal-title":"Sex Transm Infect"},{"key":"4774_CR47","doi-asserted-by":"publisher","first-page":"643422","DOI":"10.3389\/fmicb.2021.643422","volume":"12","author":"Y Han","year":"2021","unstructured":"Han Y, Liu Z, Chen T (2021a) Role of vaginal microbiota dysbiosis in gynecological diseases and the potential interventions. Front Microbiol 12:643422","journal-title":"Front Microbiol"},{"key":"4774_CR48","doi-asserted-by":"publisher","first-page":"643422","DOI":"10.3389\/fmicb.2021.643422","volume":"12","author":"Y Han","year":"2021","unstructured":"Han Y, Liu Z, Chen T (2021b) Role of vaginal microbiota dysbiosis in gynecological diseases and the potential interventions. Front Microbiol 12:643422. https:\/\/doi.org\/10.3389\/fmicb.2021.643422","journal-title":"Front Microbiol"},{"key":"4774_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10815-016-0836-8","volume":"34","author":"B Hanson","year":"2017","unstructured":"Hanson B, Johnstone E, Dorais J, Silver B, Peterson CM, Hotaling J (2017) Female infertility, infertility-associated diagnoses, and comorbidities: a review. J Assist Reprod Genet 34:167\u2013177","journal-title":"J Assist Reprod Genet"},{"key":"4774_CR50","doi-asserted-by":"crossref","unstructured":"Hibstu Z, Belew H, Akelew Y, Mengist HM (2022) Phage therapy: A different approach to fight bacterial infections. Biol Targets Ther 16:173\u2013186","DOI":"10.2147\/BTT.S381237"},{"key":"4774_CR51","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.trsl.2012.02.008","volume":"160","author":"RJ Hickey","year":"2012","unstructured":"Hickey RJ, Zhou X, Pierson JD, Ravel J, Forney LJ (2012) Understanding vaginal Microbiome complexity from an ecological perspective. Transl Res 160:267\u2013282. https:\/\/doi.org\/10.1016\/j.trsl.2012.02.008","journal-title":"Transl Res"},{"key":"4774_CR52","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s15010-013-0501-4","volume":"41","author":"C Hoffmann","year":"2013","unstructured":"Hoffmann C et al (2013) High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM. Infection 41:999\u20131003","journal-title":"Infection"},{"key":"4774_CR53","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12985-024-02510-y","volume":"21","author":"M Hosseini Hooshiar","year":"2024","unstructured":"Hosseini Hooshiar M et al (2024) The potential use of bacteriophages as antibacterial agents in dental infection. Virol J 21:258","journal-title":"Virol J"},{"key":"4774_CR54","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00404-013-2980-z","volume":"289","author":"B Hunjak","year":"2014","unstructured":"Hunjak B et al (2014) Ureaplasma urealyticum and Ureaplasma parvum in women of reproductive age. Arch Gynecol Obstet 289:407\u2013412","journal-title":"Arch Gynecol Obstet"},{"key":"4774_CR55","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s11274-014-1655-7","volume":"30","author":"SA Jassim","year":"2014","unstructured":"Jassim SA, Limoges RG (2014) Natural solution to antibiotic resistance: bacteriophages \u2018The living drugs\u2019. World J Microbiol Biotechnol 30:2153\u20132170","journal-title":"World J Microbiol Biotechnol"},{"key":"4774_CR56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.micpath.2018.11.046","volume":"127","author":"A Javed","year":"2019","unstructured":"Javed A, Parvaiz F, Manzoor S (2019) Bacterial vaginosis: an insight into the prevalence, alternative treatments regimen and it\u2019s associated resistance patterns. Microb Pathog 127:21\u201330","journal-title":"Microb Pathog"},{"key":"4774_CR57","doi-asserted-by":"publisher","first-page":"100101","DOI":"10.1016\/j.bioflm.2022.100101","volume":"5","author":"W Johnston","year":"2023","unstructured":"Johnston W et al (2023) In vitro bacterial vaginosis biofilm community manipulation using endolysin therapy. Biofilm 5:100101","journal-title":"Biofilm"},{"key":"4774_CR58","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12223-011-0039-8","volume":"56","author":"E Jo\u0144czyk","year":"2011","unstructured":"Jo\u0144czyk E, K\u0142ak M, Mi\u0119dzybrodzki R, G\u00f3rski A (2011) The influence of external factors on bacteriophages. Folia Microbiol 56:191\u2013200","journal-title":"Folia Microbiol"},{"key":"4774_CR59","doi-asserted-by":"crossref","unstructured":"Kaneko T, Nakatsuka K, Tsuneda S (2025) Phage cocktails: State-of-the-Art technologies and strategies for effective design. FEMS Microbiology Reviews, p fuaf061","DOI":"10.1093\/femsre\/fuaf061"},{"key":"4774_CR60","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/infdis\/jiaf444","volume":"232","author":"MJ Keller","year":"2025","unstructured":"Keller MJ et al (2025) Cervicovaginal secretions in young women with bacterial vaginosis enhance HIV infection. J Infect Dis 232:1436\u20131445","journal-title":"J Infect Dis"},{"key":"4774_CR62","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/GCO.0000000000000112","volume":"26","author":"CR Kenyon","year":"2014","unstructured":"Kenyon CR, Osbak K (2014) Recent progress in Understanding the epidemiology of bacterial vaginosis. Curr Opin Obstet Gynecol 26:448\u2013454","journal-title":"Curr Opin Obstet Gynecol"},{"key":"4774_CR61","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ajog.2013.05.006","volume":"209","author":"C Kenyon","year":"2013","unstructured":"Kenyon C, Colebunders R, Crucitti T (2013) The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol 209:505\u2013523","journal-title":"Am J Obstet Gynecol"},{"key":"4774_CR64","doi-asserted-by":"publisher","first-page":"e02085","DOI":"10.1128\/AEM.02085-18","volume":"84","author":"M Kim","year":"2018","unstructured":"Kim M et al (2018) Phage-antibiotic synergy via delayed Lysis. Appl Environ Microbiol 84:e02085\u2013e02018","journal-title":"Appl Environ Microbiol"},{"key":"4774_CR63","first-page":"67","volume":"39","author":"ES Kim","year":"2026","unstructured":"Kim ES, Waltmann A, Duncan JA, Hood-Pishchany I (2026) Advances in treating bacterial vaginosis: recognizing sexual transmission and pipeline of therapies. Curr Opin Infect Dis 39:67\u201374","journal-title":"Curr Opin Infect Dis"},{"key":"4774_CR65","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/humrep\/15.7.1484","volume":"15","author":"A Kinnunen","year":"2000","unstructured":"Kinnunen A et al (2000) Chlamydia trachomatis reactive T lymphocytes from upper genital tract tissue specimens. Hum Reprod 15:1484\u20131489","journal-title":"Hum Reprod"},{"key":"4774_CR66","doi-asserted-by":"publisher","first-page":"e51017","DOI":"10.1371\/journal.pone.0051017","volume":"7","author":"AE Kirby","year":"2012","unstructured":"Kirby AE (2012) Synergistic action of gentamicin and bacteriophage in a continuous culture population of Staphylococcus aureus. PLoS ONE 7:e51017","journal-title":"PLoS ONE"},{"key":"4774_CR67","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1016\/S0140-6736(18)32115-9","volume":"392","author":"MA Klebanoff","year":"2018","unstructured":"Klebanoff MA, Brotman RM (2018) Treatment of bacterial vaginosis to prevent preterm birth. Lancet 392:2141\u20132142","journal-title":"Lancet"},{"key":"4774_CR68","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrmicro2315","volume":"8","author":"SJ Labrie","year":"2010","unstructured":"Labrie SJ, Samson JE, Moineau S (2010) Bacteriophage resistance mechanisms. Nat Rev Microbiol 8:317\u2013327","journal-title":"Nat Rev Microbiol"},{"key":"4774_CR69","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.3390\/microorganisms13102410","volume":"13","author":"RF Lamont","year":"2025","unstructured":"Lamont RF, Ali A, J\u00f8rgensen JS (2025) Recent advances in the role of bacteriophages in the aetiology and therapy of vaginal dysbiosis in the form of bacterial vaginosis and the prevention of preterm birth. Microorganisms 13:2410","journal-title":"Microorganisms"},{"key":"4774_CR71","doi-asserted-by":"crossref","unstructured":"Landlinger C et al (2020) Engineered phage endolysin eliminates Gardnerella in bacterial vaginosis without damaging the healthy vaginal microbiome. medRxiv:2020.2010. 2021.20216853","DOI":"10.1101\/2020.10.21.20216853"},{"key":"4774_CR72","doi-asserted-by":"crossref","unstructured":"Landlinger C et al (2021a) Engineered phage endolysin eliminates Gardnerella biofilm without damaging beneficial bacteria in bacterial vaginosis ex vivo. Pathogens 2021; 10 (1). The potential of endolysins from Gardnerella prophages, particularly the engineered endolysin PM-477, as a highly selective and effective alternative to antibiotics for treating bacterial vaginosis.) Article PubMed PubMed Central CAS","DOI":"10.3390\/pathogens10010054"},{"key":"4774_CR73","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/pathogens10010054","volume":"10","author":"C Landlinger","year":"2021","unstructured":"Landlinger C et al (2021b) Engineered phage endolysin eliminates Gardnerella biofilm without damaging beneficial bacteria in bacterial vaginosis ex vivo. Pathogens 10:54","journal-title":"Pathogens"},{"key":"4774_CR74","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/pathogens10010054","volume":"10","author":"C Landlinger","year":"2021","unstructured":"Landlinger C et al (2021c) Engineered phage endolysin eliminates Gardnerella biofilm without damaging beneficial bacteria in bacterial vaginosis ex vivo. Pathogens 10:54","journal-title":"Pathogens"},{"key":"4774_CR70","doi-asserted-by":"publisher","first-page":"e02319","DOI":"10.1128\/aac.02319-21","volume":"66","author":"C Landlinger","year":"2022","unstructured":"Landlinger C et al (2022) Preclinical data on the Gardnerella-specific endolysin PM-477 indicate its potential to improve the treatment of bacterial vaginosis through enhanced biofilm removal and avoidance of resistance. Antimicrob Agents Chemother 66:e02319\u201302321","journal-title":"Antimicrob Agents Chemother"},{"key":"4774_CR75","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4167\/jbv.2025.55.2.091","volume":"55","author":"J-W Lee","year":"2025","unstructured":"Lee J-W, Kim J, Kim S (2025) Phage-antibiotic synergy review: Mechanisms, applications, and future prospects. J Bacteriol Virol 55:91\u2013110","journal-title":"J Bacteriol Virol"},{"key":"4774_CR76","doi-asserted-by":"publisher","first-page":"e02323","DOI":"10.1128\/aem.02323-21","volume":"88","author":"C Li","year":"2022","unstructured":"Li C, Shi T, Sun Y, Zhang Y (2022) A novel method to create efficient phage cocktails via use of phage-resistant bacteria. Appl Environ Microbiol 88:e02323\u2013e02321","journal-title":"Appl Environ Microbiol"},{"key":"4774_CR77","unstructured":"LIAN T et al (2018) Construction and identification of the Recombinant M13-IN5 phage and its effect on chlamydia trachomatis. Chin J Dermatology :859\u2013864"},{"key":"4774_CR78","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","volume":"8","author":"DM Lin","year":"2017","unstructured":"Lin DM, Koskella B, Lin HC (2017) Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther 8:162","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"4774_CR80","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12905-022-01874-z","volume":"22","author":"L Liu","year":"2022","unstructured":"Liu L et al (2022) Chlamydia infection, PID, and infertility: further evidence from a case\u2013control study in China. BMC Womens Health 22:294","journal-title":"BMC Womens Health"},{"key":"4774_CR79","doi-asserted-by":"crossref","unstructured":"Liu D, Zhang X, Zhao X, Che X, Song W, Wu G (2025a) Bacterial vaginosis: advancing insights into microbial dysbiosis. Crit Rev Microbiol 52:1\u201317","DOI":"10.1080\/1040841X.2025.2537923"},{"key":"4774_CR81","doi-asserted-by":"crossref","unstructured":"Liu Y et al (2025b) Bacteriophage combined with mNGS enhances the specificity of bacterial infection diagnosis. J Infect 91:106618","DOI":"10.1016\/j.jinf.2025.106618"},{"key":"4774_CR82","doi-asserted-by":"publisher","DOI":"10.1101\/2024.07.03.601916","author":"F MacLean","year":"2025","unstructured":"MacLean F et al (2025) Bacterial vaginosis-driven changes in cervicovaginal immunity that expand the immunological hypothesis for increased HIV susceptibility. BioRxiv. https:\/\/doi.org\/10.1101\/2024.07.03.601916","journal-title":"BioRxiv"},{"key":"4774_CR83","doi-asserted-by":"publisher","first-page":"6285","DOI":"10.48047\/fq0jjn14","volume":"54","author":"S Maitra","year":"2025","unstructured":"Maitra S et al (2025) Metronidazole Extended-Release formulation in the management of Multidrug-Resistant infections: Efficacy, Mechanisms, and therapeutic synergy with current treatment options. Cuestiones De Fisioterapia 54:6285\u20136297","journal-title":"Cuestiones De Fisioterapia"},{"key":"4774_CR84","doi-asserted-by":"publisher","first-page":"e0166757","DOI":"10.1371\/journal.pone.0166757","volume":"11","author":"K Malki","year":"2016","unstructured":"Malki K et al (2016) Genomes of Gardnerella strains reveal an abundance of prophages within the bladder Microbiome. PLoS ONE 11:e0166757","journal-title":"PLoS ONE"},{"key":"4774_CR85","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/1040841X.2020.1729695","volume":"46","author":"LD Melo","year":"2020","unstructured":"Melo LD, Oliveira H, Pires DP, Dabrowska K, Azeredo J (2020) Phage therapy efficacy: a review of the last 10 years of preclinical studies. Crit Rev Microbiol 46:78\u201399","journal-title":"Crit Rev Microbiol"},{"key":"4774_CR86","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/CMR.00035-15","volume":"28","author":"S Menon","year":"2015","unstructured":"Menon S et al (2015) Human and pathogen factors associated with chlamydia trachomatis-related infertility in women. Clin Microbiol Rev 28:969\u2013985","journal-title":"Clin Microbiol Rev"},{"key":"4774_CR87","doi-asserted-by":"publisher","first-page":"e52709","DOI":"10.1371\/journal.pone.0052709","volume":"7","author":"M Merabishvili","year":"2012","unstructured":"Merabishvili M et al (2012) Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104: H4 strain from the 2011 outbreak in Germany. PLoS ONE 7:e52709","journal-title":"PLoS ONE"},{"key":"4774_CR88","doi-asserted-by":"crossref","unstructured":"Miedzybrodzki R et al (2012) Chapter 3\u2014clinical aspects of phage therapy. Advances in Virus Research; \u0141obocka, M., Szybalski, W., Eds:73\u2013121","DOI":"10.1016\/B978-0-12-394438-2.00003-7"},{"key":"4774_CR89","doi-asserted-by":"crossref","unstructured":"Mikoulinskaia GV et al (2025) Endolysin of Aeromonas bacteriophage 3: a novel Ca2+-activated peptidoglycan hydrolase giving insight into the regulation of phage Lysis in Gram-negative bacteria. Int J Biol Macromol 322:146934","DOI":"10.1016\/j.ijbiomac.2025.146934"},{"key":"4774_CR90","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/aji.12264","volume":"71","author":"C Mitchell","year":"2014","unstructured":"Mitchell C, Marrazzo J (2014) Bacterial vaginosis and the cervicovaginal immune response. Am J Reprod Immunol 71:555\u2013563","journal-title":"Am J Reprod Immunol"},{"key":"4774_CR91","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12879-024-09379-w","volume":"24","author":"J Mongane","year":"2024","unstructured":"Mongane J et al (2024) Association between bacterial vaginosis, chlamydia trachomatis infection and tubal factor infertility in Bukavu, Democratic Republic of congo. BMC Infect Dis 24:480","journal-title":"BMC Infect Dis"},{"key":"4774_CR92","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3389\/fmicb.2018.01696","volume":"9","author":"VV Morozova","year":"2018","unstructured":"Morozova VV, Vlassov VV, Tikunova NV (2018) Applications of bacteriophages in the treatment of localized infections in humans. Front Microbiol 9:1696","journal-title":"Front Microbiol"},{"key":"4774_CR93","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s41043-024-00681-6","volume":"43","author":"M Na","year":"2024","unstructured":"Na M, Zeng L, Sun X, Huang Y, Lin M, Zhi X (2024) Relationship between chlamydia trachomatis infection, infertility, and serum 25-hydroxyvitamin D: a cross-sectional study from NHANES 2013\u20132016. J Health Popul Nutr 43:186","journal-title":"J Health Popul Nutr"},{"key":"4774_CR94","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/1471-0528.14209","volume":"124","author":"D Nasioudis","year":"2017","unstructured":"Nasioudis D, Linhares IM, Ledger WJ, Witkin SS (2017) Bacterial vaginosis: a critical analysis of current knowledge. BJOG: Int J Obstet Gynecol 124:61\u201369","journal-title":"BJOG: Int J Obstet Gynecol"},{"key":"4774_CR95","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41598-017-14943-3","volume":"8","author":"TM Nelson","year":"2018","unstructured":"Nelson TM et al (2018) Cigarette smoking is associated with an altered vaginal tract metabolomic profile. Sci Rep 8:852","journal-title":"Sci Rep"},{"key":"4774_CR96","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/antibiotics9030135","volume":"9","author":"MP Nikolich","year":"2020","unstructured":"Nikolich MP, Filippov AA (2020) Bacteriophage therapy: developments and directions. Antibiotics 9:135","journal-title":"Antibiotics"},{"key":"4774_CR97","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/v10070351","volume":"10","author":"F Oechslin","year":"2018","unstructured":"Oechslin F (2018) Resistance development to bacteriophages occurring during bacteriophage therapy. Viruses 10:351","journal-title":"Viruses"},{"key":"4774_CR98","doi-asserted-by":"crossref","unstructured":"Oliveira H, Sillankorva S, Merabishvili M, Kluskens LD, Azeredo J (2015) Unexploited opportunities for phage therapy. Front Media SA, 6:180","DOI":"10.3389\/fphar.2015.00180"},{"key":"4774_CR99","volume-title":"Chlamydia and Chlamydophila in humans and animals","author":"M Pawlikowska","year":"2012","unstructured":"Pawlikowska M, Deptu\u0142a W (2012) Chlamydia and Chlamydophila in humans and animals. University of Stettin, Stettin"},{"key":"4774_CR100","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.virusres.2015.10.025","volume":"211","author":"S Pereira","year":"2016","unstructured":"Pereira S, Pereira C, Santos L, Klumpp J, Almeida A (2016) Potential of phage cocktails in the inactivation of Enterobacter cloacae\u2014An in vitro study in a buffer solution and in urine samples. Virus Res 211:199\u2013208","journal-title":"Virus Res"},{"key":"4774_CR101","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","volume":"5","author":"A Petrovic Fabijan","year":"2020","unstructured":"Petrovic Fabijan A et al (2020) Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nat Microbiol 5:465\u2013472","journal-title":"Nat Microbiol"},{"key":"4774_CR102","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s42770-021-00624-x","volume":"52","author":"MA Rather","year":"2021","unstructured":"Rather MA, Gupta K, Mandal M (2021) Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies. Braz J Microbiol 52:1701\u20131718. https:\/\/doi.org\/10.1007\/s42770-021-00624-x","journal-title":"Braz J Microbiol"},{"key":"4774_CR103","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ajog.2020.10.019","volume":"224","author":"J Ravel","year":"2021","unstructured":"Ravel J, Moreno I, Sim\u00f3n C (2021) Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease. Am J Obstet Gynecol 224:251\u2013257","journal-title":"Am J Obstet Gynecol"},{"key":"4774_CR104","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fcimb.2020.00350","volume":"10","author":"L Riganelli","year":"2020","unstructured":"Riganelli L et al (2020) Structural variations of vaginal and endometrial microbiota: hints on female infertility. Front Cell Infect Microbiol 10:350","journal-title":"Front Cell Infect Microbiol"},{"key":"4774_CR105","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/genes16020205","volume":"16","author":"R Rodrigues","year":"2025","unstructured":"Rodrigues R, Sousa C, Barros A, Vale N (2025) Chlamydia trachomatis: from urogenital infections to the pathway of infertility. Genes 16:205","journal-title":"Genes"},{"key":"4774_CR106","unstructured":"Rohwer F, Youle M, Maughan H, Pant\u00e9a L, Darby B (2014) Life in our phage world: a centennial field guide to the Earth\u2019s most diverse inhabitants. (No Title)"},{"key":"4774_CR107","doi-asserted-by":"crossref","unstructured":"Sarier M, Rodriguez-Morales AJ (2023) Chlamydia: secret enemy from past to present. BoD\u2013Books on Demand","DOI":"10.5772\/intechopen.106108"},{"key":"4774_CR108","first-page":"1","volume":"1","author":"M Sarier","year":"2018","unstructured":"Sarier M et al (2018) Prevalence of sexually transmitted diseases in asymptomatic renal transplant recipients. Exp Clin Transpl 1:1\u20135","journal-title":"Exp Clin Transpl"},{"key":"4774_CR109","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40560-024-00759-7","volume":"12","author":"T Sawa","year":"2024","unstructured":"Sawa T, Moriyama K, Kinoshita M (2024) Current status of bacteriophage therapy for severe bacterial infections. J Intensive Care 12:44","journal-title":"J Intensive Care"},{"key":"4774_CR110","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12884-025-07144-8","volume":"25","author":"N Sethi","year":"2025","unstructured":"Sethi N et al (2025) Prevalence, risk factors, and adverse outcomes of bacterial vaginosis among pregnant women: a systematic review. BMC Pregnancy Childbirth 25:40","journal-title":"BMC Pregnancy Childbirth"},{"key":"4774_CR112","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/1751-7915.14261","volume":"16","author":"LG Sousa","year":"2023","unstructured":"Sousa LG, Pereira SA, Cerca N (2023a) Fighting polymicrobial biofilms in bacterial vaginosis. Microb Biotechnol 16:1423\u20131437","journal-title":"Microb Biotechnol"},{"key":"4774_CR113","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/1751-7915.14261","volume":"16","author":"LGV Sousa","year":"2023","unstructured":"Sousa LGV, Pereira SA, Cerca N (2023b) Fighting polymicrobial biofilms in bacterial vaginosis. Microb Biotechnol 16:1423\u20131437. https:\/\/doi.org\/10.1111\/1751-7915.14261","journal-title":"Microb Biotechnol"},{"key":"4774_CR111","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00248-024-02433-9","volume":"87","author":"LG Sousa","year":"2024","unstructured":"Sousa LG, Novak J, Fran\u00e7a A, Muzny CA, Cerca N (2024) Gardnerella vaginalis, Fannyhessea vaginae, and prevotella Bivia strongly influence each other\u2019s transcriptome in triple-species biofilms. Microb Ecol 87:117","journal-title":"Microb Ecol"},{"key":"4774_CR114","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","volume":"186","author":"SA Strathdee","year":"2023","unstructured":"Strathdee SA, Hatfull GF, Mutalik VK, Schooley RT (2023) Phage therapy: from biological mechanisms to future directions. Cell 186:17\u201331","journal-title":"Cell"},{"key":"4774_CR115","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1002\/jsfa.6222","volume":"93","author":"A Sulakvelidze","year":"2013","unstructured":"Sulakvelidze A (2013) Using lytic bacteriophages to eliminate or significantly reduce contamination of food by foodborne bacterial pathogens. J Sci Food Agric 93:3137\u20133146","journal-title":"J Sci Food Agric"},{"key":"4774_CR116","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/antibiotics14060545","volume":"14","author":"BS Supina","year":"2025","unstructured":"Supina BS, Dennis JJ (2025) The current landscape of Phage\u2013Antibiotic synergistic (PAS) interactions. Antibiotics 14:545","journal-title":"Antibiotics"},{"key":"4774_CR117","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/OLQ.0000000000001420","volume":"48","author":"S Surapaneni","year":"2021","unstructured":"Surapaneni S, Akins R, Sobel JD (2021) Recurrent bacterial vaginosis: an unmet therapeutic challenge. Experience with a combination pharmacotherapy long-term suppressive regimen. Sex Transm Dis 48:761\u2013765","journal-title":"Sex Transm Dis"},{"key":"4774_CR118","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E et al (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18:318\u2013327","journal-title":"Lancet Infect Dis"},{"key":"4774_CR119","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00404-020-05821-x","volume":"303","author":"FD Tidbury","year":"2021","unstructured":"Tidbury FD, Langhart A, Weidlinger S, Stute P (2021) Non-antibiotic treatment of bacterial vaginosis\u2014a systematic review. Arch Gynecol Obstet 303:37\u201345","journal-title":"Arch Gynecol Obstet"},{"key":"4774_CR120","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41522-025-00764-0","volume":"11","author":"LP Tisakova","year":"2025","unstructured":"Tisakova LP et al (2025) Endolysin selectively kills Gardnerella ex vivo in vaginal samples from women with bacterial vaginosis. Npj Biofilms Microbiomes 11:161","journal-title":"Npj Biofilms Microbiomes"},{"key":"4774_CR121","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1128\/AEM.02294-09","volume":"76","author":"M Tolba","year":"2010","unstructured":"Tolba M, Minikh O, Brovko L, Evoy S, Griffiths M (2010) Oriented immobilization of bacteriophages for biosensor applications. Appl Environ Microbiol 76:528\u2013535","journal-title":"Appl Environ Microbiol"},{"key":"4774_CR122","doi-asserted-by":"publisher","first-page":"119659","DOI":"10.1016\/j.ijpharm.2020.119659","volume":"587","author":"M Tomas","year":"2020","unstructured":"Tomas M, Palmeira-de-Oliveira A, Simoes S, Martinez-de-Oliveira J, Palmeira-de-Oliveira R (2020) Bacterial vaginosis: standard treatments and alternative strategies. Int J Pharm 587:119659","journal-title":"Int J Pharm"},{"key":"4774_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41426-018-0169-z","volume":"7","author":"C Torres-Barcel\u00f3","year":"2018","unstructured":"Torres-Barcel\u00f3 C (2018) The disparate effects of bacteriophages on antibiotic-resistant bacteria. Emerg Microbes Infections 7:1\u201312","journal-title":"Emerg Microbes Infections"},{"key":"4774_CR124","doi-asserted-by":"publisher","first-page":"111092","DOI":"10.1016\/j.diabres.2024.111092","volume":"207","author":"Y Tu","year":"2024","unstructured":"Tu Y et al (2024) Combined impact of hepatitis B virus and gestational diabetes mellitus on ultrasound-measured fetal growth and adverse perinatal outcomes: A seven-year retrospective study. Diabetes Res Clin Pract 207:111092. https:\/\/doi.org\/10.1016\/j.diabres.2024.111092","journal-title":"Diabetes Res Clin Pract"},{"key":"4774_CR125","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/j.1365-2672.2011.04977.x","volume":"110","author":"Y Turovskiy","year":"2011","unstructured":"Turovskiy Y, Sutyak Noll K, Chikindas ML (2011) The aetiology of bacterial vaginosis. J Appl Microbiol 110:1105\u20131128","journal-title":"J Appl Microbiol"},{"key":"4774_CR126","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.beem.2011.08.001","volume":"25","author":"D Unuane","year":"2011","unstructured":"Unuane D, Tournaye H, Velkeniers B, Poppe K (2011) Endocrine disorders & female infertility. Best Pract Res Clin Endocrinol Metab 25:861\u2013873","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"4774_CR127","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","volume":"22","author":"S Uyttebroek","year":"2022","unstructured":"Uyttebroek S et al (2022) Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review. Lancet Infect Dis 22:e208\u2013e220","journal-title":"Lancet Infect Dis"},{"key":"4774_CR128","doi-asserted-by":"publisher","first-page":"e105998","DOI":"10.1371\/journal.pone.0105998","volume":"9","author":"JH Van De Wijgert","year":"2014","unstructured":"Van De Wijgert JH et al (2014) The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS ONE 9:e105998","journal-title":"PLoS ONE"},{"key":"4774_CR129","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.1038\/s41467-022-33294-w","volume":"13","author":"B Van Nieuwenhuyse","year":"2022","unstructured":"Van Nieuwenhuyse B et al (2022) Bacteriophage-antibiotic combination therapy against extensively drug-resistant Pseudomonas aeruginosa infection to allow liver transplantation in a toddler. Nat Commun 13:5725","journal-title":"Nat Commun"},{"key":"4774_CR130","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1701-2163(15)30316-9","volume":"37","author":"J Van Schalkwyk","year":"2015","unstructured":"Van Schalkwyk J et al (2015) Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. J Obstet Gynecol Can 37:266\u2013274","journal-title":"J Obstet Gynecol Can"},{"key":"4774_CR131","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1146\/annurev-virology-100114-054915","volume":"2","author":"D Vandenheuvel","year":"2015","unstructured":"Vandenheuvel D, Lavigne R, Br\u00fcssow H (2015) Bacteriophage therapy: advances in formulation strategies and human clinical trials. Annual Rev Virol 2:599\u2013618","journal-title":"Annual Rev Virol"},{"key":"4774_CR132","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3390\/bioengineering12050469","volume":"12","author":"S Venkataraman","year":"2025","unstructured":"Venkataraman S, Shahgolzari M, Yavari A, Hefferon K (2025) Bacteriophages as targeted therapeutic vehicles: challenges and opportunities. Bioengineering 12:469","journal-title":"Bioengineering"},{"key":"4774_CR133","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coviro.2021.11.005","volume":"52","author":"G Verbeken","year":"2022","unstructured":"Verbeken G, Pirnay J-P (2022) European regulatory aspects of phage therapy: magistral phage preparations. Curr Opin Virol 52:24\u201329","journal-title":"Curr Opin Virol"},{"key":"4774_CR134","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/LGT.0000000000000647","volume":"26","author":"P Vieira-Baptista","year":"2022","unstructured":"Vieira-Baptista P, De Seta F, Verstraelen H, Ventolini G, Lonnee-Hoffmann R, Lev-Sagie A (2022) The vaginal Microbiome: V. Therapeutic modalities of vaginal Microbiome engineering and research challenges. J Lower Genit Tract Dis 26:99\u2013104","journal-title":"J Lower Genit Tract Dis"},{"key":"4774_CR135","unstructured":"Wagh P, Pandit SBR, Asmita P (2023) Study on the potential utility of phage therapy and herbal extracts for multidrug resistant Atopobium vaginae"},{"key":"4774_CR136","doi-asserted-by":"publisher","first-page":"1289644","DOI":"10.3389\/fimmu.2024.1289644","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Wu H, Fang C, Li Z (2024) Insights into innate immune cell evasion by chlamydia trachomatis. Front Immunol 15:1289644","journal-title":"Front Immunol"},{"key":"4774_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2019.04.008","volume":"267","author":"S Wei","year":"2019","unstructured":"Wei S, Liu Q, Lian T, Shao L (2019) The \u03a6CPG1 chlamydiaphage can infect chlamydia trachomatis and significantly reduce its infectivity. Virus Res 267:1\u20138","journal-title":"Virus Res"},{"key":"4774_CR138","doi-asserted-by":"crossref","unstructured":"Wei Y et al (2025) Chlamydia trachomatis infection induces ferroptosis and enhances chlamydial replication. Microb Pathog 205:107656","DOI":"10.1016\/j.micpath.2025.107656"},{"key":"4774_CR139","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12905-025-03615-4","volume":"25","author":"II Wiguna","year":"2025","unstructured":"Wiguna II, Tanoto K, Hadinata V, Chan N, Santoso BI (2025) BVBlue as a diagnostic instrument for the diagnosis of bacterial vaginosis: a systematic review. BMC Womens Health 25:90","journal-title":"BMC Womens Health"},{"key":"4774_CR140","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41522-022-00295-y","volume":"8","author":"S Wu","year":"2022","unstructured":"Wu S, Hugerth LW, Schuppe-Koistinen I, Du J (2022) The right bug in the right place: opportunities for bacterial vaginosis treatment. Npj Biofilms Microbiomes 8:34","journal-title":"Npj Biofilms Microbiomes"},{"key":"4774_CR141","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1073\/pnas.1500107112","volume":"112","author":"I Yosef","year":"2015","unstructured":"Yosef I, Manor M, Kiro R, Qimron U (2015) Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc Natl Acad Sci 112:7267\u20137272","journal-title":"Proc Natl Acad Sci"},{"key":"4774_CR142","doi-asserted-by":"publisher","first-page":"409","DOI":"10.21037\/atm-22-928","volume":"10","author":"J Yuan","year":"2022","unstructured":"Yuan J, Lai Y, Li T (2022) Ovarian protection and safety of gonadotropin-releasing hormone agonist after cervical cancer surgery: systematic review and meta-analysis. Ann Transl Med 10:409. https:\/\/doi.org\/10.21037\/atm-22-928","journal-title":"Ann Transl Med"}],"updated-by":[{"DOI":"10.1007\/s00203-026-05053-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000}}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04774-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-04774-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04774-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:03:35Z","timestamp":1785517415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-04774-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":142,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4774"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-04774-0","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00203-026-05053-8","URL":"https:\/\/doi.org\/10.1007\/s00203-026-05053-8","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of author are consent for publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"233"}}